Dermapharm Holding Future Growth

Future criteria checks 3/6

Dermapharm Holding is forecast to grow earnings and revenue by 18.1% and 4% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 18.6% in 3 years.

Key information

18.1%

Earnings growth rate

18.1%

EPS growth rate

Pharmaceuticals earnings growth	15.7%
Revenue growth rate	4.0%
Future return on equity	18.6%
Analyst coverage	Low
Last updated	15 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

WBAG:DMP - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,281	140	168	228	4
12/31/2025	1,221	130	156	214	5
12/31/2024	1,171	108	163	209	5
9/30/2024	1,176	91	157	197	N/A
6/30/2024	1,147	83	146	187	N/A
3/31/2024	1,129	57	137	179	N/A
12/31/2023	1,151	62	178	219	N/A
9/30/2023	1,172	95	240	279	N/A
6/30/2023	1,151	123	267	304	N/A
3/31/2023	1,128	146	287	323	N/A
12/31/2022	1,041	134	250	289	N/A
9/30/2022	1,024	176	222	269	N/A
6/30/2022	1,004	185	191	249	N/A
3/31/2022	980	211	190	252	N/A
12/31/2021	960	210	189	250	N/A
9/30/2021	902	162	153	209	N/A
6/30/2021	858	123	115	164	N/A
3/31/2021	828	95	96	139	N/A
12/31/2020	808	86	90	131	N/A
9/30/2020	775	80	60	104	N/A
6/30/2020	760	77	58	97	N/A
3/31/2020	743	85	69	114	N/A
12/31/2019	714	77	54	101	N/A
9/30/2019	674	73	51	90	N/A
6/30/2019	639	77	70	109	N/A
3/31/2019	611	73	84	115	N/A
12/31/2018	584	75	133	159	N/A
9/30/2018	558	75	143	165	N/A
6/30/2018	525	76	N/A	137	N/A
3/31/2018	498	79	N/A	120	N/A
12/31/2017	480	78	N/A	87	N/A
9/30/2017	486	84	N/A	84	N/A
12/31/2016	455	77	N/A	77	N/A
12/31/2015	396	13	N/A	40	N/A
12/31/2014	402	0	N/A	54	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DMP's forecast earnings growth (18.1% per year) is above the savings rate (1.4%).

Earnings vs Market: DMP's earnings (18.1% per year) are forecast to grow faster than the Austrian market (9.1% per year).

High Growth Earnings: DMP's earnings are forecast to grow, but not significantly.

Revenue vs Market: DMP's revenue (4% per year) is forecast to grow faster than the Austrian market (0.7% per year).

High Growth Revenue: DMP's revenue (4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DMP's Return on Equity is forecast to be low in 3 years time (18.6%).